Impact 2022

A Year in Biomedical Commercialization at the University of Michigan

2022 FFMI Impact Report

Fast Forward Medical Innovation (FFMI) offers funding, education, and business development resources to help biomedical researchers navigate the road to successful innovation and commercialization.

From entrepreneurial organizations on campus to partners in Michigan and across the globe, we are creating an environment and culture that nurtures technologies and supports life sciences. The ultimate goal of our research is for it to impact patients and their families.

We invite you click on the image to the left to view our latest annual report. Below are metrics that provide a snapshot of biomedical commercialization activities for the U-M Medical School’s fiscal year 2022.

Interested in a broader view of research at the University of Michigan Medical School? CLICK HERE to view the 2022 U-M Medical School Office of Research Annual Report.

INDUSTRY PARTNERSHIPS

188

Invention Reports

2021: 205
2020: 241
2019: 226

$154M

Industry Research Awards

2021: $138.3M
2020: $115.1M
2019: $118.4M

9

New Business Startups

2021: 10
2020: 16
2019: 11

189

License/Option Agreements

2021: 182
2020: 166
2019: 114

1,479

Industry Award Count

2021: 1,382
2020: 1,382
2019: 1,226

COMMERCIALIZATION EDUCATION

40M+

Follow-on Funding

awarded to date for teams that have gone through an FFMI education program

105

Commercialization Education Programs

serving biomedical innovators across the University of Michigan, and across the state, region, and nation

4,500+

Participants

enrolled in Commercialization Education programs, to date

11

Publications

describing best practice for Commercialization Education programs

355

New Innovations

from project teams at U-M and across the nation

34

Institutions

across the state, region, and nation (outside of the University of Michigan) that have participated in FFMI fastPACE

MICHIGAN BIOMEDICAL VENTURE FUND

13

Portfolio Companies

funded since launch

12 out of 13

Companies

have received follow-on funding/co-investments, (1 exited)

30:1

$30+ of Follow-On Funding

for every $1 of Michigan Biomedical Venture Fund investment

$110M+

Follow-On Funding

for all companies combined

$3.15M

Invested

in 13 companies

135+

Jobs

created

QUESTIONS?

Have questions about biomedical innovation at the University of Michigan? Contact Fast Forward Medical Innovation at ffmioffice@umich.edu.

X